Transition of Care, Part 2: Logistics, Costs, and Self-Advocacy
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Transition of Care, Part 2: Logistics, Costs, and Self-Advocacy
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In part 2, we get practical: planning treatment around family calendars and holidays, deciding between inpatient and outpatient treatment, arranging travel and temporary housing, syncing records between centers, getting financialassistance, and advocating for yourself. With insights from Dr. Joshua Dower (Stamford Health) and lived experiences from myeloma patients Kim and Annie, this episode is your playbook for navigating the details.
Topics of discussion:
(01:13) Navigating travel and scheduling for CAR T-cell therapy
(06:02) Navigating travel and scheduling for bispecific antibody therapy
(09:25) Support from the care team
(11:23) Advocating for the best possible care during transition of care
This episode is supported by Pfizer Inc.
To learn more about bispecific antibody and CAR T-cell therapy, download the Immunotherapy booklet here.
To learn more about multiple myeloma, visit themmrf.org.
To learn more about the MMRF’s FREE resources for patients and caregivers, visit the MMRF Education Hub.
If you have additional questions, call our MMRF Patient Navigation Center at 1-888-841- 6673.